Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum

Free Radical Biology and Medicine

Volumn 86, Issue , 2015, Pages 259-268

  Boon, A C ^a   Hawkins, C L ^b,c   Coombes, J S ^d   Wagner, K H ^e   Bulmer, A C ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antioxidants; Bile pigments; Chloramines; Free radicals; Heme oxygenase; Myeloperoxidase; Protein oxidation

Indexed keywords

BILIRUBIN; CHLORAMINE DERIVATIVE; MALONALDEHYDE; PEROXIDASE;

ANIMAL; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; FEMALE; GILBERT DISEASE; GUNN RAT; LIPID PEROXIDATION; MALE; METABOLISM; PHYSIOLOGY; PROTECTION;

ANIMALS; BILIRUBIN; CASE-CONTROL STUDIES; CHLORAMINES; FEMALE; GILBERT DISEASE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; PEROXIDASE; PROTECTIVE FACTORS; RATS, GUNN;

EID: 84945285459     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.05.031     Document Type: Article

References (66)

1. H.A. Schwertner, W.G. Jackson, and G. Tolan Association of low serum concentration of bilirubin with increased risk of coronary-artery disease Clin. Chem. 40 1994 18 23
2. P.N. Hopkins, L.L. Wu, S.C. Hunt, B.C. James, G.M. Vincent, and R.R. Williams Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease Arterioscler. Thromb. Vasc. Biol. 16 1996 250 255
3. L. Vitek, M. Jirsa, M. Brodanova, M. Kalab, Z. Marecek, V. Danzig, L. Novotny, and P. Kotal Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels Atherosclerosis 160 2002 449 456
4. L. Novotny, and L. Vitek Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies Exp. Biol. Med. (Maywood) 228 2003 568 571
5. R.P. Dullaart, P.J. Kappelle, and R. de Vries Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and type 2 diabetic subjects Clin. Chim. Acta 414 2012 161 165
6. S.J. Kang, D. Kim, H.E. Park, G.E. Chung, S.H. Choi, S.Y. Choi, W. Lee, J.S. Kim, and S.H. Cho Elevated serum bilirubin levels are inversely associated with coronary artery atherosclerosis Atherosclerosis 230 2013 242 248
7. S.J. Kang, C. Lee, and P. Kruzliak Effects of serum bilirubin on atherosclerotic processes Ann. Med. 46 2014 138 147
8. E.H. Temme, J. Zhang, E.G. Schouten, and H. Kesteloot Serum bilirubin and 10-year mortality risk in a Belgian population Cancer Causes Control 12 2001 887 894
9. Y.H. Chen, S.C. Hung, and D.C. Tarng Serum bilirubin links UGT1A1∗28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients Clin. J. Am. Soc. Nephrol. 6 2011 567 574
10. L.J. Horsfall, I. Nazareth, S.P. Pereira, and I. Petersen Gilbert's syndrome and the risk of death: a population-based cohort study J. Gastroenterol. Hepatol. 28 2013 1643 1647
11. R. Ajja, D.C. Lee, X. Sui, T.S. Church, and N.B. Steven Usefulness of serum bilirubin and cardiorespiratory fitness as predictors of mortality in men Am. J. Cardiol. 108 2011 1438 1442
12. A.C. Boon, A.C. Bulmer, J.S. Coombes, and R.G. Fassett Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations Am. J. Physiol. Renal Physiol. 307 2014 F123 F136
13. R. Stocker, and J.F. Keaney Jr. Role of oxidative modifications in atherosclerosis Physiol. Rev. 84 2004 1381 1478
14. J. Neuzil, and R. Stocker Bilirubin attenuates radical-mediated damage to serum albumin FEBS Lett. 331 1993 281 284
15. J. Neuzil, J.M. Gebicki, and R. Stocker Radical-induced chain oxidation of proteins and its inhibition by chain-breaking antioxidants Biochem. J. 293 1993 601 606
16. R. Stocker, A.N. Glazer, and B.N. Ames Antioxidant activity of albumin-bound bilirubin Proc. Natl. Acad. Sci. USA 84 1987 5918 5922
17. J. Neuzil, and R. Stocker Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation J. Biol. Chem. 269 1994 16712 16719
18. T.W. Wu, K.P. Fung, and C.C. Yang Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox Life Sci. 54 1994 P477 P481
19. R. Stocker, and E. Peterhans Antioxidant properties of conjugated bilirubin and biliverdin: biologically relevant scavenging of hypochlorous acid Free Radic. Res. Commun. 6 1989 57 66
20. M.J. Davies, C.L. Hawkins, D.I. Pattison, and M.D. Rees Mammalian heme peroxidases: from molecular mechanisms to health implications Antioxid. Redox Signaling 10 2008 1199 1234
21. S.J. Nicholls, and S.L. Hazen Myeloperoxidase and cardiovascular disease Arterioscler. Thromb. Vasc. Biol. 25 2005 1102 1111
22. S.J. Nicholls, and Hazen S.L. Myeloperoxidase modified lipoproteins, and atherogenesis J. Lipid Res 50 Suppl 2009 S346 S351
23. V. Kamanna, S. Ganji, and M. Kashyap Myeloperoxidase and atherosclerosis Curr. Cardiovasc. Risk Rep 7 2013 102 107
24. A. Daugherty, J.L. Dunn, D.L. Rateri, and J.W. Heinecke Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions J. Clin. Invest. 94 1994 437 444
25. 2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins Eur. J. Biochem. 267 2000 4495 4503
26. R. Purushothaman, M. Purushothaman, L.A. Carlos, A. Tarricone, M. Vasquez, P. Krishnan, A. Kini, S. Sharma, V. Fuster, and R.M. Pedro Increased myeloperoxidase expression is associated with increase in intra-plaque hemorrhage, iron content, inflammation and neovascularization in diabetic atherosclerosis: implications for plaque progression J. Cardiovasc. Dis. Diagn 1 2013 118
27. D.I. Pattison, and M.J. Davies Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases Curr. Med. Chem. 13 2006 3271 3290
28. E.L. Thomas, M.B. Grisham, and M.M. Jefferson Cytotoxicity of chloramines Methods Enzymol. 132 1986 585 593
29. C.L. Hawkins, and M.J. Davies Hypochlorite-induced oxidation of proteins in plasma: formation of chloramines and nitrogen-centred radicals and their role in protein fragmentation Biochem. J. 340 1999 539 548
30. L.J. Hazell, M.J. Davies, and R. Stocker Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins Biochem. J. 339 1999 489 495
31. R. Stocker, A. Lai, E. Peterhans, and B.N. Ames Antioxidant properties of bilirubin and biliverdin O. Hayaishi, Medical, Biochemical, and Chemical Aspects of Free Radicals Vol. 1 1988 Elsevier San Diego 465 468 Proceedings of the 4th Biennial General Meeting of the Society for Free Radical Research, Kyoto, Japan
32. K.Y. Fertrin, M.S. Goncalves, S.T. Saad, and F.F. Costa Frequencies of UDP-glucuronosyltransferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil Am. J. Med. Genet. 108 2002 117 119
33. A.C. Boon, C.L. Hawkins, K. Bisht, J.S. Coombes, B. Bakrania, K.H. Wagner, and A.C. Bulmer Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome Free Radic. Biol. Med. 52 2012 2120 2127
34. I.F. Benzie, and J.J. Strain The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay Anal. Biochem. 239 1996 70 76
35. A.C. Bulmer, J.T. Blanchfield, I. Toth, R.G. Fassett, and J.S. Coornbes Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection Atherosclerosis 199 2008 390 396
36. C.L. Hawkins, P.E. Morgan, and M.J. Davies Quantification of protein modification by oxidants Free Radic. Biol. Med. 46 2009 965 988
37. F.A. Summers, P.E. Morgan, M.J. Davies, and C.L. Hawkins Identification of plasma proteins that are susceptible to thiol oxidation by hypochlorous acid and N-chloramines Chem. Res. Toxicol. 21 2008 1832 1840
38. J.M. Dypbukt, C. Bishop, W.M. Brooks, B. Thong, H. Eriksson, and A.J. Kettle A sensitive and selective assay for chloramine production by myeloperoxidase Free Radic. Biol. Med. 39 2005 1468 1477
39. D. Londero, and P. Lo Greco Automated high-performance liquid chromatographic separation with spectrofluorometric detection of a malondialdehyde-thiobarbituric acid adduct in plasma J. Chromatogr. A 729 1996 207 210
40. Z. Cai, and L.J. Yan Protein oxidative modifications: beneficial roles in disease and health. J. Biochem Pharmacol. Res. 1 2013 15 26
41. I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, and R. Colombo Protein carbonyl groups as biomarkers of oxidative stress Clin. Chim. Acta 329 2003 23 38
42. H.A. Headlam, and M.J. Davies Markers of protein oxidation: different oxidants give rise to variable yields of bound and released carbonyl products Free Radic. Biol. Med. 36 2004 1175 1184
43. E. Malle, G. Marsche, J. Arnhold, and M.J. Davies Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid Biochim. Biophys. Acta 392-415 1761 2006
44. N.A. Strobel, R.G. Fassett, S.A. Marsh, and J.S. Coombes Oxidative stress biomarkers as predictors of cardiovascular disease Int. J. Cardiol. 147 2011 191 201
45. R. Zhang, M.L. Brennan, X. Fu, R.J. Aviles, G.L. Pearce, M.S. Penn, E.J. Topol, D.L. Sprecher, and S.L. Hazen Association between myeloperoxidase levels and risk of coronary artery disease JAMA 286 2001 2136 2142
46. M.C. Meuwese, E.S. Stroes, S.L. Hazen, J.N. van Miert, J.A. Kuivenhoven, R.G. Schaub, N.J. Wareham, R. Luben, J.J. Kastelein, K.T. Khaw, and S.M. Boekholdt Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study J. Am. Coll. Cardiol. 50 2007 159 165
47. G. Ndrepepa, S. Braun, J. Mehilli, N. von Beckerath, A. Schomig, and A. Kastrati Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes Eur. J. Clin. Invest. 38 2008 90 96
48. S.C. Hunt, F. Kronenberg, J.H. Eckfeldt, P.N. Hopkins, R.H. Myers, and G. Heiss Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study Atherosclerosis 154 2001 747 754
49. J.P. Lin, C.J. O'Donnell, J.P. Schwaiger, L.A. Cupples, A. Lingenhel, S.C. Hunt, S. Yang, and F. Kronenberg Association between the UGT1A1∗28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study Circulation 114 2006 1476 1481
50. J.R. Wagner, P.A. Motchnik, R. Stocker, H. Sies, and B.N. Ames The oxidation of blood plasma and low density lipoprotein components by chemically generated singlet oxygen J. Biol. Chem. 268 1993 18502 18506
51. R. Stocker, and E. Peterhans Synergistic interaction between vitamin E and the bile pigments bilirubin and biliverdin Biochim. Biophys. Acta 1002 1989 238 244
52. M.J. Davies, and C.L. Hawkins Hypochlorite-induced oxidation of thiols: formation of thiyl radicals and the role of sulfenyl chlorides as intermediates Free Radic. Res. 33 2000 719 729
53. C.L. Hawkins, and M.J. Davies Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation Biochem. J. 332 1998 617 625
54. C.L. Hawkins, and M.J. Davies Hypochlorite-induced damage to nucleosides: formation of chloramines and nitrogen-centered radicals Chem. Res. Toxicol. 14 2001 1071 1081
55. H. Ihara, N. Hashizume, N. Shimizu, and T. Aoki Threshold concentration of unbound bilirubin to induce neurological deficits in a patient with type I Crigler-Najjar syndrome Ann. Clin. Biochem. 36 1999 347 352
56. A.C. Bulmer, H.J. Verkade, and K.H. Wagner Bilirubin and beyond: a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection Prog. Lipid Res. 52 2013 193 205
57. K. Hagymási, I. Kocsis, G. Lengyel, P. Sipos, J. Fehér, and A. Blázovics Further evidence of altered redox status of hyperbilirubinaemic patients: role of bilirubin in Gilbert syndrome Acta Biol. Szeged 47 2003 131 134
58. S.L. Hazen, A. d'Avignon, M.M. Anderson, F.F. Hsu, and J.W. Heinecke Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to oxidize alpha-amino acids to a family of reactive aldehydes: mechanistic studies identifying labile intermediates along the reaction pathway J. Biol. Chem. 273 1998 4997 5005
59. T.J. Mocatta, A.P. Pilbrow, V.A. Cameron, R. Senthilmohan, C.M. Frampton, A.M. Richards, and C.C. Winterbourn Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction J. Am. Coll. Cardiol. 49 2007 1993 2000
60. M. Chevion, E. Berenshtein, and E.R. Stadtman Human studies related to protein oxidation: protein carbonyl content as a marker of damage Free Radic. Res 33 Suppl 2000 S99 S108
61. H.R. Griffiths, L. Moller, G. Bartosz, A. Bast, C. Bertoni-Freddari, A. Collins, M. Cooke, S. Coolen, G. Haenen, A.M. Hoberg, S. Loft, J. Lunec, R. Olinski, J. Parry, A. Pompella, H. Poulsen, H. Verhagen, and S.B. Astley Biomarkers. Mol. Aspects Med. 23 2002 101 208
62. L.J. Hazell, and R. Stocker Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages Biochem. J. 290 1993 165 172
63. L.J. Hazell, L. Arnold, D. Flowers, G. Waeg, E. Malle, and R. Stocker Presence of hypochlorite-modified proteins in human atherosclerotic lesions J. Clin. Invest. 97 1996 1535 1544
64. C. Delporte, K. Zouaoui Boudjeltia, C. Noyon, P.G. Furtmueller, V. Nuyens, M.C. Slomianny, P. Madhoun, J.M. Desmet, P. Raynal, D. Dufour, C.N. Koyani, F. Reye, A. Rousseau, M. Vanhaeverbeek, J. Ducobu, J.-C. Michalski, J. Neve, L. Vanhamme, C. Obinger, E. Malle, and P. Van Antwerpen Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100 J. Lipid Res. 55 2014 747 757
65. Z. Serdar, K. Aslan, M. Dirican, E. Sarandol, D. Yesilbursa, and A. Serdar Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease Clin. Biochem. 39 2006 794 803
66. A.C. Bulmer, J.S. Coombes, J.T. Blanchfield, I. Toth, R.G. Fassett, and S.M. Taylor Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration Br. J. Pharmacol. 164 2011 1857 1870